athenahealth splashes out $293m on mobile health firm Epocrates
This article was originally published in Clinica
Executive Summary
Electronic health record firm athenahealth has bolstered its mobile health offering by agreeing to buy Epocrates, which specialises in mobile decision support software. The agreed price, of $11.75 per share or approximately $293 million in total, represents a 22% premium over Epocrates' closing share price of $9.62 on 4 January – it is also makes the deal athenahealth's biggest acquisition to date, according to Forbes.